Literature DB >> 21553282

An automated high throughput screening-compatible assay to identify regulators of stem cell neural differentiation.

Laura Casalino1, Dario Magnani, Sandro De Falco, Stefania Filosa, Gabriella Minchiotti, Eduardo J Patriarca, Dario De Cesare.   

Abstract

The use of Embryonic Stem Cells (ESCs) holds considerable promise both for drug discovery programs and the treatment of degenerative disorders in regenerative medicine approaches. Nevertheless, the successful use of ESCs is still limited by the lack of efficient control of ESC self-renewal and differentiation capabilities. In this context, the possibility to modulate ESC biological properties and to obtain homogenous populations of correctly specified cells will help developing physiologically relevant screens, designed for the identification of stem cell modulators. Here, we developed a high throughput screening-suitable ESC neural differentiation assay by exploiting the Cell(maker) robotic platform and demonstrated that neural progenies can be generated from ESCs in complete automation, with high standards of accuracy and reliability. Moreover, we performed a pilot screening providing proof of concept that this assay allows the identification of regulators of ESC neural differentiation in full automation.

Entities:  

Mesh:

Year:  2012        PMID: 21553282     DOI: 10.1007/s12033-011-9413-7

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  21 in total

1.  A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays.

Authors: 
Journal:  J Biomol Screen       Date:  1999

Review 2.  Small molecules in cellular reprogramming and differentiation.

Authors:  Xu Yuan; Wenlin Li; Sheng Ding
Journal:  Prog Drug Res       Date:  2011

Review 3.  Evolution of cell-based reagent provision.

Authors:  Darren Cawkill; Simon S Eaglestone
Journal:  Drug Discov Today       Date:  2007-09-27       Impact factor: 7.851

4.  Stem cells and drug discovery: the beginning of a new era?

Authors:  Lee L Rubin
Journal:  Cell       Date:  2008-02-22       Impact factor: 41.582

5.  An efficient method for the detection and elimination of systematic error in high-throughput screening.

Authors:  Vladimir Makarenkov; Pablo Zentilli; Dmytro Kevorkov; Andrei Gagarin; Nathalie Malo; Robert Nadon
Journal:  Bioinformatics       Date:  2007-04-26       Impact factor: 6.937

6.  High-throughput screening assay for the identification of compounds regulating self-renewal and differentiation in human embryonic stem cells.

Authors:  Sabrina C Desbordes; Dimitris G Placantonakis; Anthony Ciro; Nicholas D Socci; Gabsang Lee; Hakim Djaballah; Lorenz Studer
Journal:  Cell Stem Cell       Date:  2008-06-05       Impact factor: 24.633

Review 7.  Derive and conquer: sourcing and differentiating stem cells for therapeutic applications.

Authors:  Irina Klimanskaya; Nadia Rosenthal; Robert Lanza
Journal:  Nat Rev Drug Discov       Date:  2008-02       Impact factor: 84.694

8.  Expression of a retinoic acid response element-hsplacZ transgene defines specific domains of transcriptional activity during mouse embryogenesis.

Authors:  J Rossant; R Zirngibl; D Cado; M Shago; V Giguère
Journal:  Genes Dev       Date:  1991-08       Impact factor: 11.361

9.  A transgenic mouse class-III beta tubulin reporter using yellow fluorescent protein.

Authors:  Li Liu; Eldon E Geisert; Anthony Frankfurter; Anthony J Spano; Chloe Xue Jiang; Junming Yue; Ioannis Dragatsis; Dan Goldowitz
Journal:  Genesis       Date:  2007-09       Impact factor: 2.487

10.  Capturing pluripotency.

Authors:  Jose Silva; Austin Smith
Journal:  Cell       Date:  2008-02-22       Impact factor: 41.582

View more
  5 in total

Review 1.  Stem cells technology: a powerful tool behind new brain treatments.

Authors:  Lucienne N Duru; Zhenzhen Quan; Talal Jamil Qazi; Hong Qing
Journal:  Drug Deliv Transl Res       Date:  2018-10       Impact factor: 4.617

Review 2.  HTS/HCS to screen molecules able to maintain embryonic stem cell self-renewal or to induce differentiation: overview of protocols.

Authors:  Genesia Manganelli; Ugo Masullo; Stefania Filosa
Journal:  Stem Cell Rev Rep       Date:  2014-12       Impact factor: 5.739

Review 3.  Induced pluripotent stem cells as a disease modeling and drug screening platform.

Authors:  Antje D Ebert; Ping Liang; Joseph C Wu
Journal:  J Cardiovasc Pharmacol       Date:  2012-10       Impact factor: 3.105

Review 4.  Translation: screening for novel therapeutics with disease-relevant cell types derived from human stem cell models.

Authors:  Stephen J Haggarty; Roy H Perlis
Journal:  Biol Psychiatry       Date:  2013-07-19       Impact factor: 13.382

Review 5.  Capturing Transitional Pluripotency through Proline Metabolism.

Authors:  Gabriella Minchiotti; Cristina D'Aniello; Annalisa Fico; Dario De Cesare; Eduardo Jorge Patriarca
Journal:  Cells       Date:  2022-07-06       Impact factor: 7.666

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.